A systematic quantitative proteomic examination of multidrug resistance in Acinetobacter baumannii

Journal of Proteomics

Volumn 84, Issue , 2013, Pages 17-39

  Chopra, Sidharth ^a,b   Ramkissoon, Kevin ^a   Anderson, D C ^a  

^a SRI INTERNATIONAL   (United States)

^b CENTRAL DRUG RESEARCH INSTITUTE   (India)

Author keywords

Acinetobacter baumannii; Multidrug resistance; Pathogenesis; Proteomics; Quantitative proteomics; Resistance mechanism

Indexed keywords

CARBAPENEM; PORIN;

ACINETOBACTER BAUMANNII; ARTICLE; BACTERIAL STRAIN; DNA SEQUENCE; LIQUID CHROMATOGRAPHY; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEOMICS; TANDEM MASS SPECTROMETRY;

ACINETOBACTER BAUMANNII; BACTERIAL PROTEINS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; PROTEOME; PROTEOMICS;

ACINETOBACTER BAUMANNII;

EID: 84876700719     PISSN: 18743919     EISSN: 18767737     Source Type: Journal    
DOI: 10.1016/j.jprot.2013.03.008     Document Type: Article

References (158)

1. Dent L., Marshall D., Pratap S., Hulette R. Multidrug resistant Acinetobacter baumannii: a descriptive study in a city hospital. BMC Infect Dis 2010, 10:196-203.
2. Dijkshoorn L., Nemec A., Seifert H. An increasing threat in hospitals: multidrug-resistant Acinetobacter baumannii. Nat Rev Microbiol 2007, 5:939-951.
3. Durante-Mangoni E., Zarrilli R. Global spread of drug-resistant Acinetobacter baumannii: molecular epidemiology and management of antimicrobial resistance. Future Microbiol 2011, 6:407-422.
4. Towner K. Acinetobacter: an old friend, but a new enemy. J Hosp Infect 2009, 73:355-363.
5. Vincent J., Rello J., Marshall J., Silva E., Anzueto A., Martin C., et al. International study of the prevalence and outcomes of infection in intensive care units. JAMA 2009, 302:2323-2329.
6. Hujer K., Hujer A., Hulten E., Bajaksouzian S., Adams J., Donskey C., et al. Analysis of antibiotic resistance genes in multidrug-resistant Acinetobacter sp. isolates from military and civilian patients treated at the Walter Reed Army Medical Center. Antimicrob Agents Chemother 2006, 50:4114-4123.
7. Bassetti M., Righi E., Esposito S., Petrosillo N., Nicolini L. Drug treatment for multidrug-resistant Acinetobacter baumannii infections. Future Microbiol 2008, 3:649-660.
8. Garcia-Garmendia J., et al. Mortality and the increase in length of stay attributable to the acquisition of Acinetobacter in critically ill patients. Crit Care Med 1999, 27:1794-1799.
9. Stuart T., Mulvey M., Simor A., Tien H., Battad A., Taylor G., et al. Acinetobacter baumannii in casualties returning from Afghanistan. Can J Infect Control 2007, 22:152-154.
10. Tien H., Battad A., Bryce E., Fuller J., Mulvey M., Bernard K., et al. Multi-drug resistant Acinetobacter infections in critically injured Canadian forces soldiers. BMC Infect Dis 2007, 7:95.
11. Zapor M., Moran K. Infectious diseases during wartime. Curr Opin Infect Dis 2005, 18:395-399.
12. Roca I., Espinal P., Vila-Farrés X., Vila J. The Acinetobacter baumannii oxymoron: commensal hospital dweller turned pan-drug-resistant menace. Front Microbiol 2012, 3:148.
13. Peleg A.Y., Seifert H., Paterson D.L. Acinetobacter baumannii: emergence of a successful pathogen. Clin Microbiol Rev 2008, 21:538-582.
14. Kochar M., Crosatti M., Harrison E., Rieck B., Chan J., Constantinidou C., et al. Deletion of TnAbaR23 results in both expected and unexpected antibiogram changes in a multidrug-resistant Acinetobacter baumannii strain. Antimicrob Agents Chemother 2012, 56:1845-1853.
15. Siroy A., Cosette P., Seyer D., Lemaître-Guillier C., Vallenet D., Van Dorsselaer A., et al. Global comparison of the membrane subproteomes between a multidrug-resistant Acinetobacter baumannii strain and a reference strain. J Proteome Res 2006, 5:3385-3398.
16. Fernández-Reyes M., Rodríguez-Falcón M., Chiva C., Pachón J., Andreu D., Rivas L. The cost of resistance to colistin in Acinetobacter baumannii: a proteomic perspective. Proteomics 2009, 9:1632-1645.
17. Yun S., Choi C., Kwon S., Park G., Cho K., Kwon K., et al. Quantitative proteomic analysis of cell wall and plasma membrane fractions from multidrug-resistant Acinetobacter baumannii. J Proteome Res 2011, 10:459-469.
18. Marti S., Nait Chabane Y., Alexandre S., Coquet L., Vila J., Jouenne T., et al. Growth of Acinetobacter baumannii in pellicle enhanced the expression of potential virulence factors. PLoS One 2011, 6:e26030.
19. Smith M., Gianoulis T., Pukatzski S., Mekalanos J., Ornston L., Gerstein M., et al. New insights into Acinetobacter baumannii pathogenesis revealed by high-density pyrosequencing and transposon mutagenesis. Genes Dev 2007, 21:601-614.
20. Poirel L., Nordmann P. Carbapenem resistance in Acinetobacter baumannii:mechanisms and epidemiology. Clin Microbiol Infect 2006, 12:826-836.
21. Wisniewski J., Zougman A., Nararaj N., Mann M. Universal sample preparation method for proteome analysis. Nat Methods 2009, 6:359-362.
22. Olsen J., de Godoy L., Li G., Macek B., Mortensen P., Pesch R., et al. Parts per million mass accuracy on an orbitrap mass spectrometer via lock mass injection into a C-trap. Mol Cell Proteomics 2005, 4:2010-2025.
23. Eng J., McCormick A., Yates J. An approach to correlate tandem mass spectral data of peptides with amino acid sequences in a protein database. J Am Soc Mass Spectrom 1994, 5:976-989.
24. Kall L., Canterbury J., Weston J., Noble W., MacCoss M. A semi-supervised machine learning technique for peptide identification from shotgun proteomics datasets. Nat Methods 2007, 4:923-925.
25. Nesvizhskii A.I., Keller A., Kolker E., Aebersold R. A statistical model for identifying proteins by tandem mass spectrometry. Anal Chem 2003, 75:4646-4658.
26. Altschul S., Gish W., Miller W., Myers E., Lipman D. Basic local alignment search tool. J Mol Biol 1990, 215:403-410.
27. Finn R., Clements J., Eddy S. HMMER web server: interactive sequence similarity searching. Nucleic Acids Res 2011, 39:W29-W37.
28. Hunter S., Jones P., Mitchell A., Apweiler R., Attwood T.K., Bateman A., et al. InterPro in 2011: new developments in the family and domain prediction database. Nucleic Acids Res 2012, 40:D306-D312.
29. Tukey J. Exploratory Data Analysis 1977, Addison-Wesley, Reading, MA.
30. Schwertman N., Owens M., Adnan R. A simple more general boxplot method for identifying outliers. Comput Stat Data Anal 2004, 47:165-174.
31. Adams M., Goglin K., Molyneaux N., Hujer K., Lavender H., Jamison J., et al. Comparative genome sequence analysis of multidrug-resistant Acinetobacter baumannii. J Bacteriol 2008, 190:8053-8064.
32. Cirz R., Chin J., Andes D., De Crécy-Lagard V., Craig W., Romesberg F. Inhibition of mutation and combating the evolution of antibiotic resistance. PLoS Biol 2005, 3:e176.
33. Ji G., Silver S. Reduction of arsenate to arsenite by the ArsC protein of the arsenic resistance operon of Staphylococcus aureus plasmid pI258. Proc Natl Acad Sci U S A 1992, 89:9474-9478.
34. Maruyama C., Hamano Y. The biological function of the bacterial isochorismatase-like hydrolase SttH. Biosci Biotechnol Biochem 2009, 73:2494-2500.
35. Asadollahi K., Taherikalani M., Maleki A., Alizadeh E., Valadbaigi H., Soroush S., et al. Diversity of aminoglycoside modifying enzyme genes among multidrug resistant Acinetobacter baumannii genotypes isolated from nosocomial infections in Tehran hospitals and their association with class 1 integrons. Acta Microbiol Immunol Hung 2011, 58:359-370.
36. Martinić M., Hoare A., Contreras I., Alvarez S. Contribution of the lipopolysaccharide to resistance of Shigella flexneri 2a to extreme acidity. PLoS One 2011, 6:e25557.
37. Mansour W., Poirel L., Bettaieb D., Bouallegue O., Boujaafar N., Nordmann P. Dissemination of OXA-23-producing and carbapenem-resistant Acinetobacter baumannii in a university hospital in Tunisia. Microb Drug Resist 2008, 14:289-292.
38. Saavedra S., Vera D., Ramírez-Ronda C. Susceptibility of aerobic Gram-negative bacilli to aminoglycosides. Effects of 45months of amikacin as first-line aminoglycoside therapy. Am J Med 1986, 80:65-70.
39. Devaud M., Kayser F., Bächi B. Transposon-mediated multiple antibiotic resistance in Acinetobacter strains. Antimicrob Agents Chemother 1982, 22:323-329.
40. Choi C., Hyun S., Kim J., Lee Y., Seol S., Cho D., et al. Nuclear translocation and DNAse I-like enzymatic activity of Acinetobacter baumannii outer membrane protein A. FEMS Microbiol Lett 2008, 288:62-67.
41. Choi C., Lee J., Lee Y., Park T., Lee J. Acinetobacter baumannii invades epithelial cells and outer membrane protein A mediates interactions with epithelial cells. BMC Microbiol 2008, 10:216.
42. Gaddy J., Tomaras A., Actis L. The Acinetobacter baumannii 19606 OmpA protein plays a role in biofilm formation on abiotic surfaces and in the interaction of this pathogen with eukaryotic cells. Infect Immun 2009, 77:3150-3160.
43. Kim S., Choi C., Moon D., Jin J., Lee J., Shin J., et al. Serum resistance of Acinetobacter baumannii through the binding of factor H to outer membrane proteins. FEMS Microbiol Lett 2009, 301:224-231.
44. Gophna U., Brodt A. CRISPR/Cas systems in archaea: what array spacers can teach us about parasitism and gene exchange in the 3rd domain of life. Mob Genet Elements 2012, 2:63-64.
45. Mussi M., Relling V., Limansky A., Viale A. CarO, an Acinetobacter baumannii outer membrane protein involved in carbapenem resistance, is essential for L-ornithine uptake. FEBS Lett 2007, 581:5573-5578.
46. Mussi M., Limansky A., Relling V., Ravasi P., Arakaki A., Actis L., et al. Horizontal gene transfer and assortative recombination within the Acinetobacter baumannii clinical population provide genetic diversity at the single carO gene, encoding a major outer membrane protein channel. J Bacteriol 2011, 193:4736-4748.
47. Whitchurch C., Leech A., Young M., Kennedy D., Sargent J., Bertrand J., et al. Characterization of a complex chemosensory signal transduction system which controls twitching motility in Pseudomonas aeruginosa. Mol Microbiol 2004, 52:873-893.
48. Walton J., Paquin C., Kaneko K., Williamson V. Resistance to antimycin A in yeast by amplification of ADH4 on a linear, 42kb palindromic plasmid. Cell 1986, 46:857-863.
49. Pringle M., Poehlsgaard J., Vester B., Long K. Mutations in ribosomal protein L3 and 23S ribosomal RNA at the peptidyl transferase centre are associated with reduced susceptibility to tiamulin in Brachyspira spp. isolates. Mol Microbiol 2004, 54:1295-1306.
50. Roberts M. Distribution of macrolide, lincosamide, streptogramin, ketolide and oxazolidinone (MLSKO) resistance genes in Gram-negative bacteria. Curr Drug Targets Infect Disord 2004, 4:207-215.
51. Cabral M., Soares N., Aranda J., Parreira J., Rumbo C., Poza M., et al. Proteomic and functional analyses reveal a unique lifestyle for Acinetobacter baumannii biofilms and a key role for histidine metabolism. J Proteome Res 2011, 10:3399-3417.
52. De Groote V., Verstraeten N., Fauvart M., Kint C., Verbeeck A., Beullens S., et al. Novel persistence genes in Pseudomonas aeruginosa identified by high-throughput screening. FEMS Microbiol Lett 2009, 297:73-79.
53. Lewis K. Multidrug tolerance of biofilms and persister cells. Curr Top Microbiol Immunol 2008, 322:107-131.
54. Kholodii G., Mindlin S., Bass I., Yurieva O., Minakhina S., Nikiforov V. Four genes, two ends, and a res region are involved in transposition of Tn5053: a paradigm for a novel family of transposons carrying either a mer operon or an integron. Mol Microbiol 1995, 17:1189-1200.
55. Han H., Jang S., Park G., Kook J., Shin J., Shin S., et al. Identification of an atypical integron carrying an IS26-disrupted aadA1 gene cassette in Acinetobacter baumannii. Int J Antimicrob Agents 2008, 32:165-169.
56. Tiwari V., Vashistt J., Kapil A., Moganty R. Comparative proteomics of inner membrane fraction from carbapenem-resistant Acinetobacter baumannii with a reference strain. PLoS One 2012, 7:e39451.
57. Chow E., Liu O., O'Brien S., Madhani H. Exploration of whole-genome responses of the human AIDS-associated yeast pathogen Cryptococcus neoformans var grubii: nitric oxide stress and body temperature. Curr Genet 2007, 52:137-148.
58. Damier-Piolle L., Magnet S., Brémont S., Lambert T., Courvalin P. AdeIJK, a resistance-nodulation-cell division pump effluxing multiple antibiotics in Acinetobacter baumannii. Antimicrob Agents Chemother 2008, 52:557-562.
59. Nishino K., Yamasaki S., Hayashi-Nishino M., Yamaguchi A. Effect of NlpE overproduction on multidrug resistance in Escherichia coli. Antimicrob Agents Chemother 2010, 54:2239-2243.
60. Nilsson A., Zorzet A., Kanth A., Dahlström S., Berg O., Andersson D. Reducing the fitness cost of antibiotic resistance by amplification of initiator tRNA genes. Proc Natl Acad Sci U S A 2006, 103:6976-6981.
61. del Mar Tomás M., Beceiro A., Pérez A., Velasco D., Moure R., Villanueva R., et al. Cloning and functional analysis of the gene encoding the 33- to 36-kDa outer membrane protein associated with carbapenem resistance in Acinetobacter baumannii. Antimicrob Agents Chemother 2005, 49:5172-5175.
62. Braun V., Braun M. Active transport of iron and siderophore antibiotics. Curr Opin Microbiol 2002, 5:194-201.
63. Zhao Y., Hammoudeh D., Yun M., Qi J., White S., Lee R. Structure-based design of novel pyrimido[4,5-c]pyridazine derivatives as dihydropteroate synthase inhibitors with increased affinity. Chem Med Chem 2012, 7:861-870.
64. McQueary C., Actis L. Acinetobacter baumannii biofilms: variations among strains and correlations with other cell properties. J Microbiol 2011, 49:243-250.
65. Lehtopolku M., Kotilainen P., Haanperä-Heikkinen M., Nakari U., Hänninen M., Huovinen P., et al. Ribosomal mutations as the main cause of macrolide resistance in Campylobacter jejuni and Campylobacter coli. Antimicrob Agents Chemother 2011, 55:5939-5941.
66. Diner E., Hayes C. Recombineering reveals a diverse collection of ribosomal proteins L4 and L22 that confer resistance to macrolide antibiotics. J Mol Biol 2009, 386:300-315.
67. Soares N., Cabral M., Gayoso C., Mallo S., Rodriguez-Velo P., Fernández-Moreira E., et al. Associating growth-phase-related changes in the proteome of Acinetobacter baumannii with increased resistance to oxidative stress. J Proteome Res 2010, 9:1951-1964.
68. Vashist J., Tiwari V., Kapil A., Rajeswari M. Quantitative profiling and identification of outer membrane proteins of beta-lactam resistant strain of Acinetobacter baumannii. J Proteome Res 2010, 9:1121-1128.
69. Liu Y., Lv T., Ren J., Wang M., Wu Q., Zhu D. The catalytic promiscuity of a microbial 7α-hydroxysteroid dehydrogenase. Reduction of non-steroidal carbonyl compounds. Steroids 2011, 76:1136-1140.
70. Juhnke H., Krems B., Kötter P., Entian K. Mutants that show increased sensitivity to hydrogen peroxide reveal an important role for the pentose phosphate pathway in protection of yeast against oxidative stress. Mol Gen Genet 1996, 52:456-464.
71. Papadopoulou B., Ouellette M. Frequent amplification of a short chain dehydrogenase gene in methotrexate resistant Leishmania. Adv Exp Med Biol 1993, 338:559-562.
72. Wawrzynow A., Banecki B., Zylicz M. The Clp ATPases define a novel class of molecular chaperones. Mol Microbiol 1996, 21:895-899.
73. Adams M., Jia Z. Structural and biochemical analysis reveal pirins to possess quercetinase activity. J Biol Chem 2005, 280:28675-28682.
74. Hihara Y., Muramatsu M., Nakamura K., Sonoike K. A cyanobacterial gene encoding an ortholog of pirin is induced under stress conditions. FEBS Lett 2004, 574:101-105.
75. Choi B., Yoon H. FKBP38-Bcl-2 interaction: a novel link to chemoresistance. Curr Opin Pharmacol 2011, 11:354-359.
76. Hansen S., Lewis K., Vulić M. Role of global regulators and nucleotide metabolism in antibiotic tolerance in Escherichia coli. Antimicrob Agents Chemother 2008, 52:2718-2726.
77. Gangaiah D., Kassem I.I., Liu Z., Rajashekara G. Importance of polyphosphate kinase 1 for Campylobacter jejuni viable-but-nonculturable cell formation, natural transformation, and antimicrobial resistance. Appl Environ Microbiol 2009, 77:7838-7849.
78. Pan-Hou H., Kiyono M., Omura H., Omura T., Endo G. Polyphosphate produced in recombinant Escherichia coli confers mercury resistance. FEMS Microbiol Lett 2002, 207:159-164.
79. Søballe B., Poole R. Ubiquinone limits oxidative stress in Escherichia coli. Microbiology 2000, 146:787-796.
80. Hodson S., Marshall J., Burston S. Mapping the road to recovery: the ClpB/Hsp104 molecular chaperone. J Struct Biol Jun 1 2012.
81. Di Capua C., Bortolotti A., Farías M.E., Cortez N. UV-resistant Acinetobacter sp. isolates from Andean wetlands display high catalase activity. FEMS Microbiol Lett 2011, 317:181-189.
82. Melis A. Photosystem-II damage and repair cycle in chloroplasts: what modulates the rate of photodamage?. Trends Plant Sci 1999, 4:130-135.
83. Kung C., Martinac B., Sukharev S. Mechanosensitive channels in microbes. Annu Rev Microbiol 2010, 6:313-329.
84. Cardoso K., Gandra R., Wisniewski E., Osaku C., Kadowaki M., Felipach-Neto V., et al. DnaK and GroEL are induced in response to antibiotic and heat shock in Acinetobacter baumannii. J Med Microbiol 2010, 59:1061-1068.
85. Freestone P., Nyström T., Trinei M., Norris V. The universal stress protein, UspA, of Escherichia coli is phosphorylated in response to stasis. J Mol Biol 1997, 274:318-324.
86. Gustavsson N., Diez A., Nyström T. The universal stress protein paralogues of Escherichia coli are co-ordinately regulated and co-operate in the defence against DNA damage. Mol Microbiol 2002, 43:107-117.
87. Linhartová I., Bumba L., Mašín J., Basler M., Osička R., Kamanová J., et al. RTX proteins: a highly diverse family secreted by a common mechanism. FEMS Microbiol Rev 2010, 34:1076-1112.
88. Welch R., Bauer M., Kent A., Leeds J., Moayeri M., Regassa L., et al. Battling against host phagocytes: the wherefore of the RTX family of toxins?. Infect Agents Dis 1995, 4:254-272.
89. Wylie J.L., Worobec E.A. The OprB porin plays a central role in carbohydrate uptake in Pseudomonas aeruginosa. J Bacteriol 1995, 177:3021-3026.
90. Catel-Ferreira M., Nehmé R., Molle V., Aranda J., Bouffartigues E., Chevalier S., et al. Deciphering the function of the outer membrane protein OprD homologue of Acinetobacter baumannii. Antimicrob Agents Chemother 2012, 56:3826-3832.
91. Leskelä S., Kontinen V.P., Sarvas M. Molecular analysis of an operon in Bacillus subtilis encoding a novel ABC transporter with a role in exoprotein production, sporulation and competence. Microbiology 1996, 142:71-77.
92. Rosado C., Kondos S., Bull T., Kuiper M., Law R., Buckle A., et al. The MACPF/CDC family of pore-forming toxins. Microbiology 2008, 10:1765-1774.
93. Acosta J., Merino M., Viedma E., Poza M., Sanz F., Otero J., et al. Multidrug-resistant Acinetobacter baumannii harboring OXA-24 carbapenemase, Spain. Emerg Infect Dis 2011, 17:1064-1067.
94. Zakharov S., Cramer W. On the mechanism and pathway of colicin import across the E. Coli outer membrane. Front Biosci 2004, 9:1311-1317.
95. Smani Y., McConnell M., Pachón J. Role of fibronectin in the adhesion of Acinetobacter baumannii to host cells. PLoS One 2012, 7:e33073.
96. Holland I., Kenny B., Blight M. Haemolysin secretion from E. coli. Biochimie 1990, 72:131-141.
97. Siroy A., Molle V., Lemaître-Guillier C., Vallenet D., Pestel-Caron M., Cozzone A., et al. Channel formation by CarO, the carbapenem resistance-associated outer membrane protein of Acinetobacter baumannii. Antimicrob Agents Chemother 2005, 49:4876-4883.
98. Javaux C., Joris B., De Witte P. Functional characteristics of TauA binding protein from TauABC Escherichia coli system. Protein J 2007, 26:231-238.
99. Basler M., Mekalanos J. Type 6 Secretion Dynamics Within and Between Bacterial Cells. Science Jul 5 2012.
100. Das D., et al. Crystal structure of the Fic (Filamentation induced by cAMP) family protein SO4266 (gi|24375750) from Shewanella oneidensis MR-1 at 1.6 A resolution. Proteins 2009, 75:264-271.
101. Seputiene V., Povilonis J., Suziedeliene E. Novel variants of AbaR resistance islands with a common backbone in Acinetobacter baumannii isolates of European clone II. Antimicrob Agents Chemother 2012, 56:1969-1973.
102. Cook P., Carney A., Holden H. Accommodation of GDP-linked sugars in the active site of GDP-perosamine synthase. Biochemistry 2008, 47:10685-10693.
103. Tsujimoto H., Gotoh N., Nishino T. Diffusion of macrolide antibiotics through the outer membrane of Moraxella catarrhalis. J Infect Chemother 1999, 5:196-200.
104. Russo T., Luke N., Beanan J.M., Olson R., Sauberan S., MacDonald U., et al. The K1 capsular polysaccharide of Acinetobacter baumannii strain 307-0294 is a major virulence factor. Infect Immun 2010, 78:3993-4000.
105. Ilan O., Bloch Y., Frankel G., Ullrich H., Geider K., Rosenshine I. Protein tyrosine kinases in bacterial pathogens are associated with virulence and production of exopolysaccharide. EMBO J 1999, 18:3241-3248.
106. Mitra A., Kitamura Y., Gasson M., Narbad A., Parr A., Payne J., et al. 4-hydroxycinnamoyl-CoA hydratase/lyase (HCHL)-An enzyme of phenylpropanoid chain cleavage from Pseudomonas. Arch Biochem Biophys 1999, 365:10-16.
107. Merali Z., Mayer M., Parker M., Michael A., Smith A., Waldron K. Metabolic diversion of the phenylpropanoid pathway causes cell wall and morphological changes in transgenic tobacco stems. Planta 2007, 225:1165-1178.
108. Clemmer K., Bonomo R., Rather P. Genetic analysis of surface motility in Acinetobacter baumannii. Microbiology 2011, 157:2534-2544.
109. Koprivnjak T., Peschel A. Bacterial resistance mechanisms against host defense peptides. Cell Mol Life Sci 2011, 68:2243-2254.
110. Swartley J., Liu L., Miller Y., Martin L., Edupuganti S., Stephens D. Characterization of the gene cassette required for biosynthesis of the alpha 1 >6-linked N-acetyl-d-mannosamine-1-phosphate capsule of serogroup A Neisseria meningitidis. J Bacteriol 1998, 180:1533-1539.
111. Mollerach M., López R., García E. Characterization of the galU gene of Streptococcus pneumoniae encoding a uridine diphosphoglucose pyrophosphorylase: a gene essential for capsular polysaccharide biosynthesis. J Exp Med 1998, 188:2047-2056.
112. Bugert P., Geider K. Molecular analysis of the ams operon required for exopolysaccharide synthesis of Erwinia amylovora. Mol Microbiol 1995, 15:917-933.
113. Dubnau D. DNA uptake in bacteria. Annu Rev Microbiol 1999, 53:217-244.
114. Roberts M. Tetracycline resistance determinants: mechanisms of action, regulation of expression, genetic mobility, and distribution. FEMS Microbiol Rev 1996, 19:1-24.
115. Stoebel D., Free A., Dorman C. Anti-silencing: overcoming H-NS-mediated repression of transcription in Gram-negative enteric bacteria. Microbiology 2008, 15:2533-2545.
116. Fang F., Rimsky S. New insights into transcriptional regulation by H-NS. Curr Opin Microbiol 2008, 11:113-120.
117. Uyen N., Park S., Choi J., Lee H., Nishi K., Kim J. The fragment structure of a putative HsdR subunit of a type I restriction enzyme from Vibrio vulnificus YJ016: implications for DNA restriction and translocation activity. Nucleic Acids Res 2009, 37:6960-6969.
118. Siddique A., Figurski D. The active partition gene incC of IncP plasmids is required for stable maintenance in a broad range of hosts. J Bacteriol 2002, 184:1788-1793.
119. Khil P., Camerini-Otero R. Over 1000 genes are involved in the DNA damage response of Escherichia coli. Mol Microbiol 2002, 44:89-105.
120. Young D., Ornston L. Functions of the mismatch repair gene mutS from Acinetobacter sp. strain ADP1. J Bacteriol 2001, 183:6822-6831.
121. Paul K., Carlquist W., Blair D. Adjusting the spokes of the flagellar motor with the DNA-binding protein H-NS. J Bacteriol 2011, 193:5914-5922.
122. Ragab A., Grüschow S., Tromans D.R., Goss R.J. Biogenesis of the unique 4',5'-dehydronucleoside of the uridyl peptide antibiotic pacidamycin. J Am Chem Soc 2011, 13:15288-15291.
123. Clissold P., Ponting C. JmjC: cupin metalloenzyme-like domains in jumonji, hairless and phospholipase A2beta. Trends Biochem Sci 2001, 26:7-9.
124. Yamagata S. Roles of O-acetyl-L-homoserine sulfhydrylases in micro-organisms. Biochimie 1989, 71:1125-1143.
125. Torkkell S., Kunnari T., Palmu K., Hakala J., Mäntsälä P., Ylihonko K. Identification of a cyclase gene dictating the C-9 stereochemistry of anthracyclines from Streptomyces nogalater. Antimicrob Agents Chemother 2000, 44:396-399.
126. Fernández-Reyes M., Rodríguez-Falcón M., Chiva C., Pachón J., Andreu D., Rivas L. The cost of resistance to colistin in Acinetobacter baumannii: a proteomic perspective. Proteomics 2008, 9:1632-1645.
127. Lee Y., Kingston A., Helmann J. Glutamate dehydrogenase affects resistance to cell wall antibiotics in Bacillus subtilis. J Bacteriol 2012, 194:993-1001.
128. Cirl C., Wieser A., Yadav M., Duerr S., Schubert S., Fischer H., et al. Subversion of Toll-like receptor signaling by a unique family of bacterial Toll/interleukin-1 receptor domain-containing proteins. Nat Med 2008, 14:399-406.
129. Sanders C.C., Iaconis J.P., Bodey G.P., Samonis G. Resistance to ticarcillin-potassium clavulanate among clinical isolates of the family Enterobacteriaceae: role of PSE-1 beta-lactamase and high levels of TEM-1 and SHV-1 and problems with false susceptibility in disk diffusion tests. Antimicrob Agents Chemother 1988, 32:1365-1369.
130. Cavallo J., Plesiat P., Couetdic G., Leblanc F., Fabre R. Mechanisms of beta-lactam resistance in Pseudomonas aeruginosa: prevalence of OprM-overproducing strains in a French multicentre study (1997). J Antimicrob Chemother 2002, 50:1039-1043.
131. Namavar F., Verboom T., van de Klundert J., van Gestel M., Zaal J., MacLarena D. Mechanisms of resistance to piperacillin of Enterobacter cloacae strains differ by antibiotic prescription policy. Int J Antimicrob Agents 1997, 8:205-208.
132. Parr T., Bryan L. Mechanism of resistance of an ampicillin-resistant, beta-lactamase-negative clinical isolate of Haemophilus influenzae type b to beta-lactam antibiotics. Antimicrob Agents Chemother 1984, 25:747-753.
133. Haller I. Importance of extracellular and cell-bound beta-lactamase in mediating resistance of Staphylococcus aureus to mezlocillin. Antimicrob Agents Chemother 1984, 25:125.
134. Eng R., Yen K., Smith S., Citron D., Goldstein E., Greenberg R., et al. Escherichia coli resistant to ampicillin/sulbactam. Chemotherapy 1992, 38:399-404.
135. Paterson D. Serious infections in the intensive care unit: Pseudomonas aeruginosa and Acinetobacter baumannii. Clin Infect Dis 2006, 43:S41-S42.
136. Paterson D., Ko W., Von Gottberg A., Mohapatra S., Casellas J., Goossens H., et al. International prospective study of Klebsiella pneumoniae bacteremia: implications of extended-spectrum beta-lactamase production in nosocomial infections. Ann Intern Med 2004, 140:26-32.
137. Jacoby G. AmpC beta-lactamases. Clin Microbiol Rev 2009, 22:161-182.
138. Píriz S., Vadillo S., Quesada A., Criado J., Cerrato R., Ayala J. Relationship between penicillin-binding protein patterns and beta-lactamases in clinical isolates of Bacteroides fragilis with different susceptibility to beta-lactam antibiotics. J Med Microbiol 2004, 53:213-221.
139. Opazo A., Sonnevend A., Lopes B., Hamouda A., Ghazawi A., Pal T., et al. Plasmid-encoded PER-7 β-lactamase responsible for ceftazidime resistance in Acinetobacter baumannii isolated in the United Arab Emirates. J Antimicrob Chemother 2012, 67:1619-1622.
140. Lee Y., Bae I., Kim J., Jeong S., Lee K. Dissemination of ceftazidime-resistant Acinetobacter baumannii clonal complex 92 in Korea. J Appl Microbiol 2012, 112:1207-1211.
141. Curcio D. Activity of a novel combination against multidrug-resistant nonfermenters: ceftazidime plus NXL104. Expert Rev Anti Infect Ther 2011, 9:173-176.
142. Okamoto M., Nakahiro R., Chin A., Bedikian A., Gill M. Cefepime: a new fourth-generation cephalosporin. Am J Hosp Pharm 1994, 51:463-477.
143. Mac Aogáin M., Kulah C., Rijnsburger M., Celebi G., Savelkoul P., O'Gara F., et al. Characterization of imipenem resistance mechanisms in Pseudomonas aeruginosa isolates from Turkey. Clin Microbiol Infect 2012, 18:E262-E265.
144. Noyal M., Menezes G., Harish B., Sujatha S., Parija S. Simple screening tests for detection of carbapenemases in clinical isolates of nonfermentative Gram-negative bacteria. Indian J Med Res 2009, 129:707-712.
145. Hamouda A., Amyes S. Novel gyrA and parC point mutations in two strains of Acinetobacter baumannii resistant to ciprofloxacin. J Antimicrob Chemother 2004, 54:695-696.
146. Saito R., Sato K., Kumita W., Inami N., Nishiyama H., Okamura N., et al. Role of type II topoisomerase mutations and AcrAB efflux pump in fluoroquinolone-resistant clinical isolates of Proteus mirabilis. J Antimicrob Chemother 2006, 58:673-677.
147. Miyachi H., Miki I., Aoyama N., Shirasaka D., Matsumoto Y., Toyoda M., et al. Primary levofloxacin resistance and gyrA/B mutations among Helicobacter pylori in Japan. Helicobacter 2006, 11:243-249.
148. Vranakis I., De Bock P., Papadioti A., Tselentis Y., Gevaert K., Tsiotis G., et al. Identification of potentially involved proteins in levofloxacin resistance mechanisms in Coxiella burnetii. J Proteome Res 2011, 10:756-762.
149. Lister P., Wolter D. Levofloxacin-imipenem combination prevents the emergence of resistance among clinical isolates of Pseudomonas aeruginosa. Clin Infect Dis 2005, 15:S105-S114.
150. Then R. Mechanisms of resistance to trimethoprim, the sulfonamides, and trimethoprim-sulfamethoxazole. Rev Infect Dis 1982, 4:261-269.
151. Sawasdidoln C., Taweechaisupapong S., Sermswan R.W., Tattawasart U., Tungpradabkul S., Wongratanacheewin S. Growing Burkholderia pseudomallei in biofilm stimulating conditions significantly induces antimicrobial resistance. PLoS One 2010, 5:e9196.
152. Eliopoulos G., Huovinen P. Resistance to trimethoprim-sulfamethoxazole. Clin Infect Dis 2001, 32:1608-1614.
153. Guardabassi L., Dijkshoorn L., Collard J., Olsen J., Dalsgaard A. Distribution and in-vitro transfer of tetracycline resistance determinants in clinical and aquatic Acinetobacter strains. J Med Microbiol 2000, 49:929-936.
154. Donabedian S., Thal L., Hershberger E., Perri B., Chow J., Bartlett P., et al. Molecular characterization of gentamicin-resistant Enterococci in the United States: evidence of spread from animals to humans through food. J Clin Microbiol 2003, 41:1109-1113.
155. Fournier P., Vallenet D., Barbe V., Audic S., Ogata H., Poirel L., et al. Comparative genomics of multidrug resistance in Acinetobacter baumannii. PLoS Genet 2006, 2:e7.
156. Henriques I., Fonseca F., Alves A., Saavedra M., Correia A. Tetracycline-resistance genes in Gram-negative isolates from estuarine waters. Lett Appl Microbiol 2008, 47:526-533.
157. Chopra S., Torres-Ortiz M., Hokama L., Madrid P., Tanga M., Mortelmans K., et al. Repurposing FDA-approved drugs to combat drug-resistant Acinetobacter baumannii. J Antimicrob Chemother 2010, 65:2598-2601.
158. Nwugo C., Gaddy J., Zimbler D., Actis L. Deciphering the iron response in Acinetobacter baumannii: a proteomics approach. J Proteomics 2011, 74:44-58.